Statements in which the resource exists as a subject.
PredicateObject
rdf:type
entrezgene:pubmed
pubmed-article:11427703, pubmed-article:11595185, pubmed-article:11726971, pubmed-article:11805336, pubmed-article:12006492, pubmed-article:12379843, pubmed-article:12388682, pubmed-article:12598123, pubmed-article:12663786, pubmed-article:12743307, pubmed-article:12900394, pubmed-article:12915533, pubmed-article:14505569, pubmed-article:14505570, pubmed-article:14519844, pubmed-article:14581576, pubmed-article:15168195, pubmed-article:15218037, pubmed-article:15256501, pubmed-article:15795524, pubmed-article:16138902, pubmed-article:16234236, pubmed-article:16470130, pubmed-article:16571793, pubmed-article:16808324, pubmed-article:16940516, pubmed-article:17083721, pubmed-article:17556548, pubmed-article:17942528, pubmed-article:17982468, pubmed-article:18005716, pubmed-article:18267010, pubmed-article:18321968, pubmed-article:18367816, pubmed-article:18789977, pubmed-article:19020832, pubmed-article:19053244, pubmed-article:19064259, pubmed-article:19099395, pubmed-article:19143627, pubmed-article:19244744, pubmed-article:19282983, pubmed-article:19401538, pubmed-article:19802344, pubmed-article:19914066, pubmed-article:20012524, pubmed-article:20018238, pubmed-article:20088757, pubmed-article:20427536, pubmed-article:20712566, pubmed-article:21070952, pubmed-article:21110817, pubmed-article:21152581, pubmed-article:21159863, pubmed-article:21505419, pubmed-article:21643473, pubmed-article:21666754, pubmed-article:21762796, pubmed-article:21762798, pubmed-article:21841072, pubmed-article:21875593, pubmed-article:22004035, pubmed-article:22291694, pubmed-article:22421880, pubmed-article:22754649, pubmed-article:22761998, pubmed-article:23027949
entrezgene:interactant
entrezgene:geneRifText
A genetically selected cyclic peptide IYWNVSGW inhibits HIV budding by targeting the interaction between the p6 domain of Gag and TSG101. The inhibitory activity of the peptide is PT/SAP dependent, A short helix (helix-1; amino acid residues 14-18) in HIV-1 p6 enhances the binding of the p6 PTAP motif (residues 7-10) to TSG101, AIP1 binds to the LXXLF motif in HIV-1 p6 (amino acids 41-44) and also binds to TSG101 to act as a component of the viral budding machinery, ESCRT-I complexes contain three common subunits (TSG101, VPS28, and VPS37), and a fourth subunit MVB12. Recombinant ESCRT-I complexes bind HIV-1 p6, Employing N-alkylglycine ('peptoid') residues to the p6-derived 9-mer sequence 'PEPTAPPEE' improves peptide binding affinity to the ubiquitin E2 variant domain of TSG101, Expression of HIV-1 Gag attenuates SDF-1-mediated downregulation of CXCR4. The effect of Gag is dependent on a TSG101 interacting motif within the C-terminal p6 region of Gag, Expression of HIV-1 Gag attenuates SDF-1-mediated downregulation of CXCR4. This effect of Gag is dependent on a TSG101 interacting motif within the C-terminal p6 region of Gag, NEDD4L-mediated stimulation of virus budding is dependent upon the ubiquitin ligase activity of NEDD4L and requires only the minimal HIV-1 Gag assembly regions and TSG101, TSG101 binding to HIV-1 Gag correlates with redistribution of IP3R to the plasma membrane, Tal, a Tsg101-associated ligase, binds and ubiquitylates Tsg101; Tal-mediated binding and ubiquitylation of Tsg101 cooperatively regulate release of HIV-1 Gag, The Bro1 domain of Alix inhibits HIV budding by targeting both PTAP/TSG101 and LYPXnL/Alix pathways. The NC domain of Gag is the primary target for Bro1 inhibition by Gag-mediated recruitment of Bro1 to the plasma membrane, The PTAP sequence (179-182) in the GAT domain and the PSAP sequence (310-313) in the C-terminal region of Tom1L1 are required for its interaction with the UEV domain (1-145) of Tsg101 and competes with HIV-1 Gag, The direct binding of the UEV domain (amino acids 1-145) of TSG101 to the L domain (amino acids 7-10) of HIV-1 p6-Gag is essential for the p6 directed budding of HIV-1 virions from infected cells, The hydroxyl of the Thr or Ser residue in the P(S/T)AP motif of HIV-1 Gag forms hydrogen bonds with the main chain of Asn69. Mutation of the Asn to Pro abrogates PTAP motif binding to TSG101 and blocks budding of HIV-1 from cells, The hydroxyl of the Thr or Ser residue in the P(S/T)AP motif of HIV-1 p6 forms hydrogen bonds with the main chain of Asn69. Mutation of the Asn to Pro abrogates PTAP motif binding to TSG101 and blocks budding of HIV-1 from cells, The p1 spacer peptide in HIV-1 Gag can confer a requirement for Tsg101 binding. Removal of NC-p1 region from authentic HIV-1 alleviates sensitivity to dominant-negative CHMP3, The p6 domain of HIV-1 Gag mimics the Tsg101-recruiting activity of the human Hrs protein, Tsg 101, VPS 28, and VPS 37B form the human endosomal sorting complex required for transport (ESCRT-I), which is required for HIV-1 Gag budding and virus infectivity
entrezgene:keyphrase
interacts with, regulated by, binds, recruits, complexes with